BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28922524)

  • 1. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
    Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
    J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
    Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
    Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
    Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders.
    Xu XQ; Qian W; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Acta Radiol; 2019 Feb; 60(2):239-246. PubMed ID: 29804475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
    Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
    J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI.
    Sun B; Song L; Wang X; Li J; Xian J; Wang F; Tan P
    J Magn Reson Imaging; 2017 May; 45(5):1438-1445. PubMed ID: 27649521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions.
    Lecler A; Balvay D; Cuenod CA; Marais L; Zmuda M; Sadik JC; Galatoire O; Farah E; El Methni J; Zuber K; Bergès O; Savatovsky J; Fournier L
    J Magn Reson Imaging; 2019 Nov; 50(5):1514-1525. PubMed ID: 30989761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
    Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
    Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
    Erb-Eigner K; Asbach P; Ro SR; Haas M; Bertelmann E; Pietsch H; Schwenke C; Taupitz M; Denecke T; Hamm B; Lawaczeck R
    Acta Radiol; 2019 May; 60(5):643-652. PubMed ID: 30114927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI of orbital and anterior visual pathway lesions.
    Jittapiromsak N; Hou P; Liu HL; Sun J; Schiffman JS; Chi TL
    Magn Reson Imaging; 2018 Sep; 51():44-50. PubMed ID: 29709464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
    Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
    Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods.
    Chen W; Hu H; Chen HH; Su GY; Yang T; Xu XQ; Wu FY
    Acta Radiol; 2020 Nov; 61(11):1512-1519. PubMed ID: 32053002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: whole-tumor quantitative perfusion for prediction of immediate ablation response.
    Li C; Jin C; Liang T; Li X; Wang R; Zhang Y; Yang J
    Acta Radiol; 2020 Aug; 61(8):1125-1133. PubMed ID: 31779469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.